Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Sarfez Pharmaceuticals
Sarfez Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Soaanz
Torsemide
2021-06-14
2033
Heart failure
,
Hypertension
,
Chronic kidney failure
,
Liver cirrhosis
,
Nephrotic syndrome
,
Edema
,
Ascites
,
Pulmonary edema
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Torsemide
malnutrition
,
therapeutic equivalency
,
type 2 diabetes mellitus
,
diabetes mellitus
,
biotransformation
,
food-drug interactions
,
body weight
,
body weight changes
,
healthy volunteers/patients
,
disease
,
pre-eclampsia
,
overactive urinary bladder
,
urinary incontinence
,
genetic predisposition to disease
,
heart failure
,
hypertension
,
edema
,
chronic renal insufficiency
,
kidney diseases
,
renal insufficiency
,
cardiovascular diseases
,
tricuspid valve insufficiency
,
fibrosis
,
mitral valve insufficiency
,
covid-19
,
drug-related side effects and adverse reactions
,
drug interactions
Sodium chloride
healthy volunteers/patients
,
osteoarthritis
,
major depressive disorder
,
depressive disorder
,
prostatic hyperplasia
,
hyperplasia
,
knee osteoarthritis
,
cicatrix
,
skin aging
,
pruritus
,
carpal tunnel syndrome
,
hypertrophy
,
premature birth
,
premature ejaculation
,
neuralgia
,
hyperalgesia
,
surgical wound
,
penile induration
,
torticollis
,
thoracic outlet syndrome
,
amyotrophic lateral sclerosis
,
motor neuron disease
,
abdominoplasty
,
musculoskeletal pain
,
systemic lupus erythematosus
,
syndrome
,
headache
,
pelvic pain
,
dystonic disorders
,
dystonia
,
myofascial pain syndromes
,
fibromyalgia
,
somatoform disorders
,
cerebral palsy
,
parkinson disease
,
temporomandibular joint disorders
,
facial pain
,
temporomandibular joint dysfunction syndrome
,
acrodynia
,
systemic scleroderma
,
raynaud disease
,
localized scleroderma
,
diffuse scleroderma
,
urinary bladder diseases
,
multiple sclerosis
,
neurogenic urinary bladder
,
sclerosis
,
breast neoplasms
,
neoplasms
,
postoperative pain
,
breast diseases
,
hereditary breast and ovarian cancer syndrome
,
paresis
,
patellofemoral pain syndrome
,
prostatitis
,
chronic disease
,
overactive urinary bladder
,
muscle spasticity
,
stroke
,
migraine disorders
,
urinary incontinence
,
enuresis
,
depression
,
interstitial cystitis
,
cystitis
,
facies
,
eye diseases
,
wounds and injuries
,
brain injuries
,
shoulder pain
,
pain
,
aging
,
graves ophthalmopathy
,
spinal cord injuries
,
microbial drug resistance
,
obesity
,
adiposity
,
postoperative nausea and vomiting
,
bariatric surgery
,
vomiting
,
nausea
,
keratoconjunctivitis sicca
,
dry eye syndromes
,
herpes simplex
,
herpes labialis
,
breast implants
,
inflammation
,
intraocular pressure
,
muscle strength
,
clostridium botulinum type a
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use